• Je něco špatně v tomto záznamu ?

Naphyrone (naphthylpyrovalerone): Pharmacokinetics, behavioural effects and thermoregulation in Wistar rats

N. Pinterova-Leca, RR. Horsley, H. Danda, M. Žídková, E. Lhotková, K. Šíchová, K. Štefková, M. Balíková, M. Kuchař, T. Páleníček

. 2021 ; 26 (2) : e12906. [pub] 20200507

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012509

Naphthylpyrovalerone (naphyrone) is a pyrovalerone cathinone that potently inhibits monoamine transporters and provides stimulatory-entactogenic effects. Little is known about the safety of naphyrone or its effects in vivo, and more research is needed to acquire knowledge about its fundamental effects on physiology and behaviour. Our objective was to investigate naphyrone's pharmacokinetics, acute toxicity, hyperthermic potential and stimulatory and psychotomimetic properties in vivo in male Wistar rats. Pharmacokinetics after 1 mg/kg subcutaneous (sc.) naphyrone were measured over 6 h in serum, the brain, liver and lungs. Rectal temperature (degree Celsius) was measured over 10 h in group-versus individually housed rats after 20 mg/kg sc. In the behavioural experiments, 5, 10 or 20 mg/kg of naphyrone was administered 15 or 60 min prior to testing. Stimulation was assessed in the open field, and sensorimotor processing in a prepulse inhibition (PPI) task. Peak concentrations of naphyrone in serum and tissue were reached at 30 min, with a long-lasting elevation in the brain/serum ratio, consistent with observations of lasting hyperlocomotion in the open field and modest increases in body temperature. Administration of 20 mg/kg transiently enhanced PPI. Naphyrone crosses the blood-brain barrier rapidly and is eliminated slowly, and its long-lasting effects correspond to its pharmacokinetics. No specific signs of acute toxicity were observed; therefore, clinical care and harm-reduction guidance should be in line with that available for other stimulants and cathinones.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012509
003      
CZ-PrNML
005      
20231213104856.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/adb.12906 $2 doi
035    __
$a (PubMed)32378298
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pinterova-Leca, Nikola $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $1 https://orcid.org/0000000162424413 $7 xx0258135
245    10
$a Naphyrone (naphthylpyrovalerone): Pharmacokinetics, behavioural effects and thermoregulation in Wistar rats / $c N. Pinterova-Leca, RR. Horsley, H. Danda, M. Žídková, E. Lhotková, K. Šíchová, K. Štefková, M. Balíková, M. Kuchař, T. Páleníček
520    9_
$a Naphthylpyrovalerone (naphyrone) is a pyrovalerone cathinone that potently inhibits monoamine transporters and provides stimulatory-entactogenic effects. Little is known about the safety of naphyrone or its effects in vivo, and more research is needed to acquire knowledge about its fundamental effects on physiology and behaviour. Our objective was to investigate naphyrone's pharmacokinetics, acute toxicity, hyperthermic potential and stimulatory and psychotomimetic properties in vivo in male Wistar rats. Pharmacokinetics after 1 mg/kg subcutaneous (sc.) naphyrone were measured over 6 h in serum, the brain, liver and lungs. Rectal temperature (degree Celsius) was measured over 10 h in group-versus individually housed rats after 20 mg/kg sc. In the behavioural experiments, 5, 10 or 20 mg/kg of naphyrone was administered 15 or 60 min prior to testing. Stimulation was assessed in the open field, and sensorimotor processing in a prepulse inhibition (PPI) task. Peak concentrations of naphyrone in serum and tissue were reached at 30 min, with a long-lasting elevation in the brain/serum ratio, consistent with observations of lasting hyperlocomotion in the open field and modest increases in body temperature. Administration of 20 mg/kg transiently enhanced PPI. Naphyrone crosses the blood-brain barrier rapidly and is eliminated slowly, and its long-lasting effects correspond to its pharmacokinetics. No specific signs of acute toxicity were observed; therefore, clinical care and harm-reduction guidance should be in line with that available for other stimulants and cathinones.
650    _2
$a zvířata $7 D000818
650    _2
$a tělesná teplota $x účinky léků $7 D001831
650    _2
$a termoregulace $x účinky léků $7 D001833
650    _2
$a stimulanty centrálního nervového systému $x farmakokinetika $x farmakologie $7 D000697
650    _2
$a zakázané drogy $x farmakokinetika $x farmakologie $7 D013287
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pentanony $x farmakokinetika $x farmakologie $7 D010422
650    _2
$a pyrrolidiny $x farmakokinetika $x farmakologie $7 D011759
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Horsley, Rachel R $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic $1 https://orcid.org/0000000325362465
700    1_
$a Danda, Hynek, $d 1988- $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $7 xx0311507
700    1_
$a Žídková, Monika $u Institute of Forensic Medicine and Toxicology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/000000017891277X $7 xx0207762
700    1_
$a Lhotková, Eva $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Šíchová, Klára $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Štefková, Kristýna $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Balíková, Marie $u Institute of Forensic Medicine and Toxicology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000163341177 $7 jn99240000049
700    1_
$a Kuchař, Martin $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic $u Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology in Prague, Prague, Czech Republic
700    1_
$a Páleníček, Tomáš $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic $u Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $1 https://orcid.org/0000000231099539
773    0_
$w MED00006247 $t Addiction biology $x 1369-1600 $g Roč. 26, č. 2 (2021), s. e12906
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32378298 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20231213104852 $b ABA008
999    __
$a ok $b bmc $g 1789914 $s 1163710
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 26 $c 2 $d e12906 $e 20200507 $i 1369-1600 $m Addiction biology $n Addict Biol $x MED00006247
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...